Recent research, turned into shippable ideas
Let's bridge the gap between research and industry. We discover latest research and derive commercially plausible innovation ideas through interactive artifacts.
A flood of research. A trickle of impact.
Millions of papers are published every year and the majority of those never actually reaches the people.
research papers published every year — and doubling roughly every 9 years.
WordsRated, on Scopus / Web of Science outputaverage lag from a research finding to reaching everyday practice.
Morris, Wooding & Grant, J R Soc Med (2011)of original research findings ever make it into everyday clinical practice.
Westfall et al., JAMA (2007); orig. Balas & Boren (2000)inventions are never commercialised — lost in the “valley of death”.
The Asymmetric, “The innovation valley of death”From paper to prototype
A fully automated pipeline, with a human in the loop where it matters.
We continuously pull recent, highly-cited work from OpenAlex across the domains you care about.
Each finding is distilled into one concrete, commercially plausible product idea — grounded in real target customers.
An interactive prototype is generated, gated, and auto-deployed to its own URL so you can try the idea immediately.
Latest ideas
Concrete concepts derived from recent research — each with a live prototype.
A high-potential companion diagnostic that leverages a specific genetic/metabolic bottleneck to solve the 'non-responder' problem in the massive GLP-1RA market.
Backed by 3 papers
A high-potential drug discovery play that leverages a specific structural discovery to decouple antidepressant efficacy from hallucinogenic side effects.
Backed by 4 papers
A highly focused, scientifically grounded assay service that targets a specific pharmacological gap in the high-value psychedelic-derivative drug market.
Backed by 3 papers
A highly focused, evidence-backed decision tool for government infrastructure planning with a clear value proposition and a specific entry point.
Backed by 3 papers
A highly focused B2B tool that transforms academic LCA and energy-saving models into a practical decision-support tool for automotive material selection.
Backed by 5 papers
A highly focused, evidence-backed seed program targeting a specific, high-demand crop failure with a clear genetic pathway to restoration.
A high-conviction tool for enterprise agent safety that replaces stochastic prompting with a deterministic, formally verified execution boundary.
Backed by 6 papers
A high-potential precision medicine diagnostic with a clear clinical wedge, though it relies on a relatively narrow set of mouse-model findings for its primary efficacy claim.
Backed by 2 papers
A timely professional certification for a high-growth, high-risk clinical niche, though it faces significant regulatory uncertainty regarding the 'drug vs. therapy' distinction.
Backed by 14 papers
A high-value B2B tool that transforms a technical optimization process into a commercial certification asset for Tier-1 suppliers to justify premium material costs to OEMs.
Backed by 3 papers
A highly focused B2B hardware-software tool that solves a specific R&D pain point for dental material manufacturers by combining two validated preclinical methods.
Backed by 3 papers
A highly focused, evidence-backed tool that solves a specific regulatory and commercial pain point for logistics firms adopting eHighway technology.
A highly specialized simulation tool for a high-stakes regulatory transition (Tier 5), leveraging strong academic convergence on off-road emission challenges.
Backed by 5 papers
A highly focused, high-value B2B tool that replaces expensive physical testing with a validated simulation wedge for a specific automotive failure point.
A highly focused, evidence-backed agricultural product that solves a specific productivity crisis for Rwandan bean farmers using a proven breeding strategy.
Backed by 2 papers
A highly feasible, specialized software optimization for EV powertrain control that translates specific driver preference data into a competitive drivability advantage.
A focused software enhancement for EV drivability that leverages specific jerk and kurtosis data to bridge the UX gap between ICE and EV drivers.
Backed by 2 papers
A promising, evidence-backed biological fungicide with a clear industrial application, though it faces significant regulatory hurdles and competition from established bio-fungicides.
A technically sound data-as-a-service play that leverages strong research to provide high-resolution urban emission data, though it faces a challenging B2G sales cycle and potential competition from map incumbents.
Backed by 2 papers
A viable, evidence-backed simulation tool for urban planners, though it faces significant competition from established GIS and traffic modeling incumbents.
Backed by 2 papers
Frequently asked questions
Everything you need to know about how Seedlabs works.
See what the latest research makes possible
Browse the catalogue of ideas, try the live prototypes, and tell us which ones are worth building.